Secondary metabolite produced from marine bacterium Streptomyces sp. strain ND7c

2018 ◽  
Vol 54(5) ◽  
pp. 88
Author(s):  
Phuong, T.V. ◽  
Diep, C.N. ◽  
Lam, P.V.H. ◽  
Chu, D.X.
2016 ◽  
Vol 4 (5) ◽  
Author(s):  
Samantha M. Gromek ◽  
Anne A. Sung ◽  
Jonathan L. Klassen ◽  
Marcy J. Balunas

Streptomyces sp. PTY087I2 is a marine bacterium isolated from Styela canopus , a tunicate collected in Bocas del Toro, Panama. Here, we report a draft genome sequence for this bacterium, found to have 94.7% average nucleotide identity (ANI) with Streptomyces roseosporus NRRL 11379, and containing a diverse suite of secondary metabolite gene clusters.


2021 ◽  
Vol 85 (3) ◽  
pp. 714-721
Author(s):  
Risa Takao ◽  
Katsuyuki Sakai ◽  
Hiroyuki Koshino ◽  
Hiroyuki Osada ◽  
Shunji Takahashi

ABSTRACT Recent advances in genome sequencing have revealed a variety of secondary metabolite biosynthetic gene clusters in actinomycetes. Understanding the biosynthetic mechanism controlling secondary metabolite production is important for utilizing these gene clusters. In this study, we focused on the kinanthraquinone biosynthetic gene cluster, which has not been identified yet in Streptomyces sp. SN-593. Based on chemical structure, 5 type II polyketide synthase gene clusters were listed from the genome sequence of Streptomyces sp. SN-593. Among them, a candidate gene cluster was selected by comparing the gene organization with grincamycin, which is synthesized through an intermediate similar to kinanthraquinone. We initially utilized a BAC library for subcloning the kiq gene cluster, performed heterologous expression in Streptomyces lividans TK23, and identified the production of kinanthraquinone and kinanthraquinone B. We also found that heterologous expression of kiqA, which belongs to the DNA-binding response regulator OmpR family, dramatically enhanced the production of kinanthraquinones.


1991 ◽  
Vol 113 (12) ◽  
pp. 4682-4683 ◽  
Author(s):  
Dianne M. Tapiolas ◽  
Mark Roman ◽  
William Fenical ◽  
Thomas J. Stout ◽  
Jon Clardy

2017 ◽  
Vol 5 (21) ◽  
Author(s):  
Jianguo Xu ◽  
Min Xu ◽  
Kai Liu ◽  
Qinyin Peng ◽  
Meifeng Tao

ABSTRACT Streptomyces sp. Sge12 was isolated from forest soil and exhibited remarkable antimicrobial activities against selected fungi and Gram-positive bacteria. Here, we report the complete genome sequence of this strain, which contains 37 putative secondary metabolite gene clusters.


Author(s):  
Ema Damayanti ◽  
Jaka Widada ◽  
Puspa Dewi N. Lotulung ◽  
Achmad Dinoto ◽  
Mustofa Mustofa

Genome mining study showed that marine-derived Streptomyces sp. GMY01 is a potential actinobacteria with abundant of secondary metabolite and anticancer activity. The study aimed to evaluate bioassay guided fractionation for antiplasmodial screening of GMY01 extract and to predict compound on active fractions. Ethyl acetate fraction was obtained from 11 days fermentation product of GMY01 and then it was fractionated using n-hexane and methanol solvent. Refractionated was applied using flash chromatography and column chromatography. Antiplasmodial assay was performed on Plasmodium falciparum FCR3 by microscopic method using thin blood smear + Giemsa stain, and flow cytometry method using SYBR Green I stain. Toxicity assay was performed on Vero cells line. Main constituent of active fraction was analyzed using LCMS/MS. The result of the study showed that ethyl acetate-methanol fraction has high antiplasmodial activity (IC50=3.96 µg/mL) with very low toxicity on Vero cells (IC50=30,072 µg/mL). Bioassay guided fractionation resulted F4.7 as highest Plasmodium inhibition (94.3% at 5 µg/mL) and was confirmed by microscopic and flow cytometry assay. Main constituent analysis showed C10H13NO (163.09971 Da) as mayor compound and predicted as nonribosomal polyketide synthetase (NRPS) secondary metabolite.


Author(s):  
Loh Teng-Hern Tan ◽  
Learn-Han Lee ◽  
Bey-Hing Goh

A single Streptomyces strain often have the potential to produce more than one bioactive compound. Fermentation parameters include media compositions, temperature and pH, have great impact on the secondary metabolism of Streptomyces and subsequently on production of different microbial products. This review aims to consolidate the studies on the cultivation parameters used to enhance the production of secondary metabolite with anti-Vibrio activity from a single Streptomyces strain. In turn, this review sheds light on the possible alterations of the cultivation parameters to obtain desired anti-Vibrio compounds from Streptomyces sp. Furthermore, the bioactive compounds with anti-Vibrio activity identified from Streptomyces sp. were demonstrated to exhibit immense values for future antibacterial agent developments.


ChemInform ◽  
2010 ◽  
Vol 31 (10) ◽  
pp. no-no
Author(s):  
Matthew K. Renner ◽  
Ya-Ching Shen ◽  
Xing-Chung Cheng ◽  
Paul R. Jensen ◽  
Walter Frankmoelle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document